About
Bionaut Labs is a biotechnology start-up focused on treating central nervous system disorders (CNS) with its Bionaut precision medicine treatment modality. Bionaut uses remote-controlled microscale robots to deliver biologics, nucleic acids, or small molecule therapies locally to targeted CNS disease areas. Through precision localized brain targeting, Bionaut therapeutics could offer better efficacy and safety that cannot be achieved by other traditional treatment modalities.
Two of the company's earliest indications are for gliomas and Huntington's disease. The Bionaut therapeutic-containing drug targets a disease similarly to how a traditional modality targets a disease. Bionauts are custom-engineered therapeutic micro-robots that target payloads to specific locations in the body. Bionauts can be constructed in different versions with custom geometries and surface characteristics. Smaller than a millimeter, they contain moving parts controlled remotely by a compact magnetic controller, allowing them to move.
Funding history · 3 rounds · $69.2M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Bionaut Labs' primary focus?
- Bionaut Labs is a biotechnology startup focused on treating central nervous system (CNS) disorders using its Bionaut precision medicine treatment modality, which involves remote-controlled microscale robots.
- When was Bionaut Labs founded and where is its headquarters located?
- Bionaut Labs was founded in January 2016 and is headquartered in Herzliya, Israel, with an additional office in Los Angeles, CA, USA.
- What is the core technology behind Bionaut Labs' treatment modality?
- Bionaut Labs utilizes custom-engineered therapeutic micro-robots, smaller than a millimeter, that are remotely controlled by a compact magnetic controller to deliver therapies locally to targeted CNS disease areas.
- What are some of the earliest indications Bionaut Labs is targeting with its technology?
- Bionaut Labs' earliest indications for its therapeutic micro-robots are gliomas and Huntington's disease.
- What was Bionaut Labs' first significant funding round, and who were the lead investors?
- In March 2021, Bionaut Labs raised a Series A round of $20 million, with Khosla Ventures as the lead investor.
- When did Bionaut Labs raise its Series B funding, and what was the amount?
- Bionaut Labs raised a Series B round of $43.2 million in November 2022, with Khosla Ventures leading the investment.
- Did Bionaut Labs receive any additional Series B funding after November 2022?
- Yes, in February 2024, Bionaut Labs raised an additional $6 million in a Series B extension round, with investors including OurCrowd, Upfront Ventures, Mayo Clinic Platform, and Khosla Ventures.
- What is the total amount of funding Bionaut Labs has raised to date?
- According to startupim data, Bionaut Labs has raised a total of $69.2 million USD.
- How many employees does Bionaut Labs currently have?
- Bionaut Labs currently has 42 employees.